Designing inhaled small molecule drugs for severe respiratory diseases: an overview of the challenges and opportunities
Cornelia H. Rinderknecht, Christian M. Gampe(ETH Zurich), Connie Wu, Mark S. Wilson(Gene Therapy Laboratory), Miaoran Ning
Cited by 4
Related Papers
Type 2 immunity in tissue repair and fibrosis
|Nature reviews. Immunology|2017|1.1k
Pulmonary fibrosis: pathogenesis, etiology and regulation
|Mucosal Immunology|2009|834
Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and Fibrosis
|PLoS Pathogens|2009|808
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
|The Journal of Experimental Medicine|2010|740
Suppression of allergic airway inflammation by helminth-induced regulatory T cells
|The Journal of Experimental Medicine|2005|609